Anlon Healthcare (AHCL) — Board Meeting

📢 Key Event
Board approved Q1 FY2026-27 results and subsidiary acquisitions via equity swap

🔮 What's Next
July 30, 2026 effective date for acquisition completion

💡 Investor Takeaway
Shareholders gain controlling stakes in two healthcare firms through non-cash acquisition

Anlon Healthcare Limited approved unaudited Q1 FY2026-27 results showing ₹3,103.52 lakhs total income and [amount context mismatch] lakhs profit after tax, while authorizing non-cash equity issuance to acquire 32.52% of Apiqo Organics and 43.33% of Bizotic LifeScience, making them wholly owned subsidiaries. The board confirmed full utilization of IPO proceeds with no deviations from approved objects, maintaining unchanged financing plans and obtaining all statutory approvals.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AHCL ✨ Ask AI About This

About Anlon Healthcare Limited (AHCL)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹709.57 Cr

View full AHCL stock details →

📡 Get AI alerts when AHCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AHCL — Free

💡 Ask AI about this filing

"When will the share swap become effective?" "What is the valuation of Apiqo Organics and Bizotic LifeScience?" "How will the acquisition affect AHCL's consolidated margins?"

Ask AI Free →

📊 More AHCL filings

See all AHCL filings →

🔥 Also filed on 30 July 2026

PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document AJANTPHARM Ajanta Pharma Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action AYMSYNTEX AYM Syntex Limited Announcement GILLETTE Gillette India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AHCL files new disclosures

Track AHCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.